Senjor E, Perišić M, Breznik B, Mitrović A, Mlakar J, Rotter A, Porčnik A, Lah Turnšek T, Kos J.

Cystatin F acts as a mediator of immune suppression in glioblastoma.

Cellular oncology 2021; 44, 1051-63.

Rus T, Tomše P, Jensterle L, Ležaić L, Limbäck Stokin C, Popović M, Tang CC, Eidelberg D, Pirtošek Z, Trošt M.

Atypical clinical presentation of pathologically proven Parkinson’s disease: The role of Parkinson’s disease related metabolic pattern. Parkinson’s disease related metabolic pattern.

Parkinsonism and related disorders 78 (2020) 1-3.

Strojnik T, Kavalar R, Gornik-Kramberger K, Rupnik M, Lorencic Robnik S, Popovic M, Velnar T.

Latent brain infection with Moraxella osloensis as a possible cause of cerebral gliomatosis type 2: A case report.

World J Clin Oncol 2020 December 24; 11(12): 1064-1069.

Clarke M1…..Popović M35 ….Jones C1 (75 soavtorjev).

Infant high-grade gliomas comprise multiple subgroups characterised by novel targetable gene fusions and fevorable ourcomes.

Cancer discovery.

Matjašič A, Zupan A, Boštjančič E, Pižem J, Popović M, Kolenc D.

A novel PTPRZ1-ETV1 fusion in gliomas.

Brain Pathology 30 (2020) 226–234.

Bošnjak M, Zupan A, Fiorini M, Popović KŠ, Popović M.

A case of MV2K subtype of sporadic Creutzfeldt-Jakob disease with florid-like plaques: Similarities and differences to variant Creutzfeldt-Jakob disease.

Neuropathology. 2020 Aug; 40(4): 389-398.

Hira VVV., Breznik B, Vittori M, Jong AL, Mlakar J, Oostra RJ, Khurshed M, Molenaar RJ, Lah Turnšek T, Noorden CJF.

Similarities between stem cell niches in glioblastoma and bone marrow : rays of hope for novel treatment strategies.

The Journal of histochemistry and cytochemistry. 2020, vol. 68, no. 1, str. 33-57. ISSN 0022-1554.

Novak M, Koprivnikar Krajnc M, Hrastar B, Breznik B, Majc B, Mlinar M, Rotter A, Porčnik A, Mlakar J, Stare K, Pestell RG, Lah Turnšek T.

CCR5-mediated signaling is involved in invasion of glioblastoma cells in its microenvironment.

International journal of molecular sciences. 12 Jun. 2020, vol. 21, iss. 12, str. 1-20, ilustr. ISSN 1422-0067.

Zottel A, Jovchevska I, Šamec N, Mlakar J, Šribar J, Križaj I, Skoblar Vidmar M, Komel R.

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration.

Therapeutic advances in medical oncology. 2020, vol. 12, str. 1-29, ilustr. ISSN 1758-8359.